OPEN END TURBO OPTIONSSCHEIN SHORT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000GG0BPX3

Real-time BOERSE MUENCHEN 11:55:04 24/06/2024 pm IST
3.042 EUR -2.06% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - FRESENIUS MEDICAL CARE
Current month+10.62%
1 month+10.10%
Date Price Change
24/24/24 3.042 -2.06%
21/24/21 3.106 +3.12%
20/24/20 3.012 -1.95%
19/24/19 3.072 +2.85%
18/24/18 2.987 +1.53%

Real-time BOERSE MUENCHEN

Last update June 24, 2024 at 11:55 pm IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer Goldman Sachs
WKN GG0BPX
ISINDE000GG0BPX3
Date issued 28/11/2023
Strike 66.56
Maturity Unlimited
Parity 10 : 1
Emission price 3.13
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.377
Lowest since issue 2.592

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.68 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.03%
Consensus